Abstract: A fluid control assembly is connected between a cold gas container intended to be operated at deep cryogenic temperatures (e.g., 4K) and a gas reservoir for controlling the flow of fluid between the container and the reservoir. The fluid control assembly may be a passive valve assembly or an electrically controlled valve assembly which controls fluid flow between the reservoir and the container as a function of temperature and/or pressure differentials. The fluid control assembly enables the container to be rapidly cooled by restricting the amount of fluid flow from the reservoir into the container when the container is subjected to thermal cycling within a limited temperature range (e.g., 4K to 11K). The fluid control assembly together with the gas reservoir and the container form a thermal damper which is suited for use in a cryocooling system for producing the cryogenic temperatures (e.g., 4K) to operate superconducting devices which may need to be thermally cycled to remove trapped flux.

Abstract: A fluid control assembly is connected between a cold gas container intended to be operated at deep cryogenic temperatures (e.g., 4K) and a gas reservoir for controlling the flow of fluid between the container and the reservoir. The fluid control assembly may be a passive valve assembly or an electrically controlled valve assembly which controls fluid flow between the reservoir and the container as a function of temperature and/or pressure differentials. The fluid control assembly enables the container to be rapidly cooled by restricting the amount of fluid flow from the reservoir into the container when the container is subjected to thermal cycling within a limited temperature range (e.g., 4K to 11K). The fluid control assembly together with the gas reservoir and the container form a thermal damper which is suited for use in a cryocooling system for producing the cryogenic temperatures (e.g., 4K) to operate superconducting devices which may need to be thermally cycled to remove trapped flux.

Abstract: A chimeric therapeutic agent recognizing iNOS utilizing a human/mouse chimeric anti-hiNOS monoclonal antibody having mouse complimentarity-determining regions forming a binding site for iNOS.

Abstract: A treatment for SIRS, sepsis, severe sepsis and septic shock in a mammalian subject by utilizing a method and therapeutic agent for inhibiting the binding of particulate iNOS to cells. The agent takes the form of a cellular receptor antagonist.

Abstract: A seal for use within the interior portions of a piston, primarily on a diesel engine which has a pressurized oil supply which is forced upwardly through the connecting rod and sprayed on to the upper portion of the piston. The seal substantially closes the area between the connecting rod and the interior sidewalls of the piston skirt. The oil is thus restricted in flow, building up pressure within the top portion of the piston and causing the oil to contact the upper interior portion for cooling the piston and further, forced to lubricate the bushings on the wrist pin.

Abstract: A seal for use within the interior portions of a piston, primarily on a diesel engine which has a pressurized oil supply which is forced upwardly through the connecting rod and sprayed on to the upper portion of the piston. The seal substantially closes the area between the connecting rod and the interior sidewalls of the piston skirt. The oil is thus restricted in flow, building up pressure within the top portion of the piston and causing the oil to contact the upper interior portion for cooling the piston and further, forced to lubricate the bushings on the wrist pin.